<DOC>
	<DOCNO>NCT02072408</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety aflibercept treatment polypoidal choroidal vasculopathy without active polyp .</brief_summary>
	<brief_title>Efficacy Safety Intravitreal Vascular Endothelial Growth Factor Trap-eye Patients With Polyploidal Choroidal Vasculopathy</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<criteria>polypoidal choroidal vasculopathy without active polyp decrease visual acuity subretinal fluid hemorrhage involve foveal center polypoidal choroidal vasculopathy active polyp previous photodynamic therapy three time antiVEGF injection within one month photodynamic therapy intraocular steroid treatment within three month</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>